During the past decade, APT Foundation conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 7 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "APT Foundation" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 16 trials as a collaborator, "APT Foundation, Inc." with 5 trials as a collaborator, "Yale University" with 2 trials as a collaborator and "Robert Wood Johnson Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "APT Foundation" are "Opioid-Related Disorders" (6 trials), "Substance-Related Disorders" (5 trials), "Opiate Dependence" (4 trials), "Substance Abuse" (3 trials) and "Cocaine-Related Disorders" (2 trials). Many other conditions were trialed in "APT Foundation" in a lesser frequency.

Most popular intervention types in "APT Foundation" are "Behavioral" (13 trials), "Drug" (8 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Buprenorphine" (5 trials), "3H+ (Holistic Health for HIV)" (1 trials), "BDRC" (1 trials), "Behavior Therapy" (1 trials) and "Behavioral: Buprenorphine/naloxone detoxification (Dtx)" (1 trials). Other intervention names were less common.

The vast majority of trials in "APT Foundation" are 19 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "APT Foundation". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in APT Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in APT Foundation, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".